{"links":{"self":"https://clientapi.gcs-web.com/data/33381f6d-8eaa-46ae-8c63-71b3672717c2/filings/28916/html"},"meta":{"executionDate":"2026-07-15T23:05:41","cmsDomain":"https://bradyid.gcs-web.com"},"data":"\n\n\n\n\n\n\n\nbrc-20240522
00007465982024Q3false00007465982024-05-222024-05-22

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 22, 2024
BRADY CORPORATION
(Exact name of registrant as specified in its charter)
Commission File Number 1-14959
Wisconsin 39-0178960
(State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.)
6555 West Good Hope Road
Milwaukee, Wisconsin 53223
(Address of principal executive offices and Zip Code)
(414) 358-6600
(Registrant’s Telephone Number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Class A Nonvoting Common Stock, par value $0.01 per shareBRCNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐


Item 2.02RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On May 22, 2024, Brady Corporation (the “Company”) issued a press release announcing its fiscal 2024 third quarter financial results. A copy of the press release is being furnished to the Securities and Exchange Commission as Exhibit 99.1 attached hereto and is incorporated herein by reference.

Item 7.01REGULATION FD DISCLOSURE

On May 22, 2024, the Company hosted a conference call related to its fiscal 2024 third quarter financial results. A copy of the slides referenced in the conference call, which is also posted on the Company’s website, is being furnished to the Securities and Exchange Commission as Exhibit 99.2 attached hereto and is incorporated herein by reference.

Item 9.01FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits
EXHIBIT NUMBERDESCRIPTION
99.1
99.2
104Cover Page Interactive Data File (embedded within Inline XBRL document).

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  BRADY CORPORATION
Date: May 22, 2024 
 /s/ ANN E. THORNTON
 Ann E. Thornton
 Chief Financial Officer, Chief Accounting Officer and Treasurer


\n\n
\n\n\nDocument

EXHIBIT 99.1


For More Information:
Investor contact: Ann Thornton 414-438-6887
Media contact: Kate Venne 414-358-5176


Brady Corporation Reports Record EPS in its Fiscal 2024 Third Quarter and Raises its Fiscal 2024 EPS Guidance

•Sales for the quarter increased 1.9 percent compared to the same quarter of the prior year. Organic sales increased 4.5 percent, foreign currency decreased sales by 0.3 percent and divestitures decreased sales by 2.3 percent.
•Diluted EPS increased 9.4 percent to a record high of $1.05 in the third quarter of fiscal 2024 compared to $0.96 in the same quarter of the prior year. Diluted EPS Excluding Certain Items* increased 14.7 percent to a record high of $1.09 in the third quarter of fiscal 2024 compared to $0.95 in the same quarter of the prior year.
•Net cash provided by operating activities was $171.1 million in the nine months ended April 30, 2024 compared to $129.9 million in the nine months ended April 30, 2023.
•Earnings per diluted Class A Common Share guidance was raised for the full year ending July 31, 2024 from the previous range of $3.80 to $3.95 to the new range of $3.93 to $4.00 on a GAAP basis, and was raised from the previous range of $3.95 to $4.10 to the new range of $4.08 to $4.15 on a non-GAAP basis.

MILWAUKEE (May 22, 2024) -- Brady Corporation (NYSE: BRC) (“Brady” or “Company”), a world leader in identification solutions, today reported its financial results for its fiscal 2024 third quarter ended April 30, 2024.

Quarter Ended April 30, 2024 Financial Results:
Sales for the quarter ended April 30, 2024 increased 1.9 percent, which consisted of organic sales growth of 4.5 percent, a decrease of 0.3 percent from foreign currency translation and a decrease of 2.3 percent from divestitures. Sales for the quarter ended April 30, 2024 were $343.4 million compared to $337.1 million in the same quarter last year. By region, sales increased 0.9 percent in the Americas & Asia and increased 3.8 percent in Europe & Australia, which consisted of organic sales growth of 4.5 percent in the Americas & Asia and organic sales growth of 4.4 percent in Europe & Australia.
Income before income taxes increased 2.2 percent to $64.4 million for the quarter ended April 30, 2024, compared to $63.0 million in the same quarter last year. Income Before Income Taxes Excluding Certain Items* for the quarter ended April 30, 2024, which was adjusted for amortization expense in both periods, and removes the $3.8 million pre-tax gain on a divestiture from the same quarter last year, was $66.8 million, an increase of 8.2 percent.
Net income for the quarter ended April 30, 2024 was $50.9 million compared to $48.1 million in the same quarter last year. Earnings per diluted Class A Nonvoting Common Share were $1.05 in the third quarter of fiscal 2024, compared to $0.96 in the same quarter last year. Net Income Excluding Certain Items* for the quarter ended April 30, 2024 was $52.7 million and Diluted EPS Excluding Certain Items* for the quarter ended April 30, 2024 was $1.09. Net Income Excluding Certain Items* for the quarter ended April 30, 2023 was $47.6 million and Diluted EPS Excluding Certain Items* for the quarter ended April 30, 2023 was $0.95.



Nine-Month Period Ended April 30, 2024 Financial Results:
Sales for the nine-month period ended April 30, 2024 increased 1.2 percent, which consisted of organic sales growth of 3.0 percent, an increase of 0.6 percent from foreign currency translation and a decrease of 2.4 percent from divestitures. Sales for the nine months ended April 30, 2024 were $998.0 million compared to $985.9 million in the same period last year. By region, sales decreased 0.5 percent in the Americas & Asia and increased 4.7 percent in Europe & Australia, which consisted of organic sales growth of 3.0 percent in the Americas & Asia and organic sales growth of 2.8 percent in Europe & Australia.
Income before income taxes increased 11.0 percent to $179.6 million for the nine-month period ended April 30, 2024, compared to $161.9 million in the same period last year. Income Before Income Taxes Excluding Certain Items* for the nine months ended April 30, 2024, which was adjusted for amortization expense in both periods and removes the $3.8 million pre-tax gain on a divestiture from the same period last year, was $186.7 million, an increase of 11.5 percent compared to the same period of the prior year.
Net income for the nine-month period ended April 30, 2024 was $141.8 million compared to $125.5 million in the same period last year. Earnings per diluted Class A Nonvoting Common Share were $2.91 for the nine months ended April 30, 2024, compared to $2.51 in the same period last year. Net Income Excluding Certain Items* for the nine months ended April 30, 2024 was $147.2 million and Diluted EPS Excluding Certain Items* for the nine months ended April 30, 2024 was $3.03. Net Income Excluding Certain Items* for the nine months ended April 30, 2023 was $130.3 million, and Diluted EPS Excluding Certain Items* for the nine months ended April 30, 2023 was $2.60.

Commentary:
“This quarter we reported all-time record high EPS and strong organic sales growth. Our ongoing investment in research and development continues to add value for our customers and increase organic sales. This quarter we launched several exciting new products that separate us from our competition and complement our current product offering. We remain focused on innovation and on our consistent priorities, which we believe will continue to drive future growth,” said Brady’s President and Chief Executive Officer, Russell R. Shaller. “Both regions performed extremely well this quarter and we are facilitating an increased pace of innovative new product development, which we believe positions us for future success.”
“In addition to our organic revenue growth of 4.5 percent and record EPS this quarter, we also used our strong balance sheet and cash generation to return funds to our shareholders in the form of share buybacks and dividends. This quarter, we repurchased a total of 863,365 shares for $50.4 million and we returned another $11.2 million to our shareholders in the form of dividends,” said Brady’s Chief Financial Officer, Ann Thornton. “Our balance sheet provides significant opportunities to invest in both organic opportunities and strategic acquisitions in order to drive long-term shareholder value.”

Fiscal 2024 Guidance:
The Company raised its GAAP earnings per diluted Class A Nonvoting Common Share guidance for the year ending July 31, 2024 from the previous guidance range of $3.80 to $3.95 per share to the new full year guidance range of $3.93 to $4.00 per share. The Company raised its Diluted EPS Excluding Certain Items* guidance for the year ending July 31, 2024 from the previous range of $3.95 to $4.10 per share to the new full year guidance range of $4.08 to $4.15 per share.


The assumptions included in fiscal 2024 guidance include a full-year income tax rate of approximately 21 percent and depreciation and amortization expense ranging from $30 million to $32 million. Capital expenditures are expected to approximate $75 million, which is inclusive of facility purchase and construction costs of approximately $55 million. Fiscal 2024 guidance is based on foreign currency exchange rates as of April 30, 2024 and assumes continued economic growth. Fiscal 2024 guidance does not include the Company’s pending acquisition of Gravotech Holding, which is expected to close by the end of its fiscal year ending July 31, 2024. Excluding acquisition-related costs, Brady expects the acquisition of Gravotech Holding to be immaterial to earnings per share in fiscal 2024.

A webcast regarding Brady’s fiscal 2024 third quarter financial results will be available at www.bradycorp.com/investors beginning at 9:30 a.m. central time today.

Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady’s products help customers increase safety, security, productivity and performance and include high-performance labels, signs, safety devices, printing systems and software. Founded in 1914, the Company has a diverse customer base in electronics, telecommunications, manufacturing, electrical, construction, medical, aerospace and a variety of other industries. Brady is headquartered in Milwaukee, Wisconsin and as of July 31, 2023, employed approximately 5,600 people in its worldwide businesses. Brady’s fiscal 2023 sales were approximately $1.33 billion. Brady stock trades on the New York Stock Exchange under the symbol BRC. More information is available on the Internet at www.bradyid.com.


* Income Before Income Taxes Excluding Certain Items, Net Income Excluding Certain Items, and Diluted EPS Excluding Certain Items are non-GAAP measures. See appendix for more information on these measures, including reconciliations to the most directly comparable GAAP measures.

###

In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, earnings, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project,” “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: the occurrence of any event, change or other circumstances that could give rise to the termination of the offer to acquire Gravotech; the expected timing and likelihood of completion of the proposed transaction with Gravotech, including the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the offer that could reduce anticipated benefits or cause the parties to abandon the transaction; the risk that the proposed offer and its announcement could have an adverse effect on the ability of Brady and Gravotech to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on their operating results and businesses generally; increased cost of raw materials and labor as well as material shortages and supply chain disruptions; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; difficulties in protecting our websites, networks, and systems against security breaches; Brady’s ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses; risks associated with the loss of key employees; extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities; litigation, including product liability claims; adverse impacts of


regional epidemics or global pandemics; foreign currency fluctuations; potential write-offs of goodwill and other intangible assets; changes in tax legislation and tax rates; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady’s Form 10-K for the year ended July 31, 2023.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.


BRADY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited; Dollars in thousands, except per share data)

Three months ended April 30,Nine months ended April 30,
 2024202320242023
Net sales$343,384 $337,116 $997,991 $985,934 
Cost of goods sold166,357 167,425 487,162 504,539 
Gross margin177,027 169,691 510,829 481,395 
Operating expenses:
Research and development17,681 15,715 50,215 45,025 
Selling, general and administrative95,803 90,975 283,415 273,202 
Total operating expenses113,484 106,690 333,630 318,227 
Operating income63,543 63,001 177,199 163,168 
Other income (expense):
Investment and other income1,596 785 4,718 1,596 
Interest expense(728)(753)(2,284)(2,886)
Income before income taxes64,411 63,033 179,633 161,878 
Income tax expense13,521 14,981 37,874 36,399 
Net income$50,890 $48,052 $141,759 $125,479 
Net income per Class A Nonvoting Common Share:
Basic$1.06 $0.97 $2.94 $2.52 
Diluted$1.05 $0.96 $2.91 $2.51 
Net income per Class B Voting Common Share:
Basic$1.06 $0.97 $2.92 $2.51 
Diluted$1.05 $0.96 $2.90 $2.49 
Weighted average common shares outstanding:
Basic48,004 49,653 48,294 49,755 
Diluted48,386 50,001 48,640 50,033 



BRADY CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)

 April 30, 2024July 31, 2023
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents$160,458 $151,532 
Accounts receivable, net of allowance for credit losses of $6,690 and $8,467, respectively195,099 184,420 
Inventories153,272 177,078 
Prepaid expenses and other current assets12,443 11,790 
Total current assets521,272 524,820 
Property, plant and equipment—net194,732 142,149 
Goodwill588,095 592,646 
Other intangible assets53,893 62,096 
Deferred income taxes14,881 15,716 
Operating lease assets27,438 29,688 
Other assets23,785 22,142 
Total$1,424,096 $1,389,257 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$79,965 $79,855 
Accrued compensation and benefits73,697 71,470 
Taxes, other than income taxes14,462 13,575 
Accrued income taxes7,945 12,582 
Current operating lease liabilities12,230 14,726 
Other current liabilities64,850 65,828 
Total current liabilities253,149 258,036 
Long-term debt63,774 49,716 
Long-term operating lease liabilities15,552 16,217 
Other liabilities69,519 74,369 
Total liabilities401,994 398,338 
Stockholders’ equity:
Common stock:
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 43,941,713 and 45,008,724 shares, respectively513 513 
Class B voting common stock—Issued and outstanding, 3,538,628 shares35 35 
Additional paid-in capital354,432 351,771 
Retained earnings1,129,739 1,021,870 
Treasury stock—7,319,774 and 6,252,763 shares, respectively of Class A nonvoting common stock, at cost(356,210)(290,209)
Accumulated other comprehensive loss(106,407)(93,061)
Total stockholders’ equity1,022,102 990,919 
Total$1,424,096 $1,389,257 



BRADY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited; Dollars in thousands)

Nine months ended April 30,
20242023
Operating activities:
Net income$141,759 $125,479 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization22,406 24,522 
Stock-based compensation expense6,422 6,427 
Gain on sale of business— (3,770)
Deferred income taxes(6,902)(5,947)
Other1,358 (1,336)
Changes in operating assets and liabilities:
Accounts receivable(15,915)1,744 
Inventories20,861 9,279 
Prepaid expenses and other assets(1,849)(3,429)
Accounts payable and accrued liabilities7,347 (19,704)
Income taxes(4,393)(3,404)
Net cash provided by operating activities171,094 129,861 
Investing activities:
Purchases of property, plant and equipment(69,157)(12,912)
Sale of business— 8,000 
Other(1,174)11 
Net cash used in investing activities(70,331)(4,901)
Financing activities:
Payment of dividends(33,890)(34,202)
Proceeds from exercise of stock options5,583 4,091 
Payments for employee taxes withheld from stock-based awards(2,664)(1,965)
Purchase of treasury stock(72,225)(29,774)
Proceeds from borrowing on credit agreement111,790 102,916 
Repayment of borrowing on credit agreement(97,732)(147,067)
Other149 66 
Net cash used in financing activities(88,989)(105,935)
Effect of exchange rate changes on cash and cash equivalents(2,848)1,953 
Net increase in cash and cash equivalents8,926 20,978 
Cash and cash equivalents, beginning of period151,532 114,069 
Cash and cash equivalents, end of period$160,458 $135,047 



BRADY CORPORATION AND SUBSIDIARIES
SEGMENT INFORMATION
(Unaudited; Dollars in thousands)

Three months ended April 30,Nine months ended April 30,
2024202320242023
NET SALES
Americas & Asia$224,766 $222,813 $658,035 $661,375 
Europe & Australia118,618 114,303 339,956 324,559 
Total$343,384 $337,116 $997,991 $985,934 
SALES INFORMATION
Americas & Asia
Organic4.5 %1.2 %3.0 %4.0 %
Currency(0.1)%(0.8)%— %(1.1)%
Divestiture(3.5)%(0.3)%(3.5)%(0.1)%
Total0.9 %0.1 %(0.5)%2.8 %
Europe & Australia
Organic4.4 %3.4 %2.8 %7.0 %
Currency(0.6)%(4.8)%1.9 %(10.1)%
Total3.8 %(1.4)%4.7 %(3.1)%
Total Company
Organic4.5 %1.9 %3.0 %5.0 %
Currency(0.3)%(2.1)%0.6 %(4.1)%
Divestiture(2.3)%(0.2)%(2.4)%(0.1)%
Total1.9 %(0.4)%1.2 %0.8 %
SEGMENT PROFIT
Americas & Asia$49,697 $49,192 $143,489 $130,511 
Europe & Australia19,537 17,099 51,335 47,316 
Total segment profit$69,234 $66,291 $194,824 $177,827 
SEGMENT PROFIT AS A PERCENT OF NET SALES
Americas & Asia22.1 %22.1 %21.8 %19.7 %
Europe & Australia16.5 %15.0 %15.1 %14.6 %
Total20.2 %19.7 %19.5 %18.0 %
Three months ended April 30,Nine months ended April 30,
2024202320242023
Total segment profit$69,234 $66,291 $194,824 $177,827 
Unallocated amounts:
Administrative costs(5,691)(7,060)(17,625)(18,429)
Gain on sale of business— 3,770 — 3,770 
Investment and other income1,596 785 4,718 1,596 
Interest expense(728)(753)(2,284)(2,886)
Income before income taxes$64,411 $63,033 $179,633 $161,878 



GAAP to NON-GAAP MEASURES
(Unaudited; Dollars in Thousands, Except Per Share Amounts)
In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure.
Income Before Income Taxes Excluding Certain Items:
Brady is presenting the non-GAAP measure, "Income Before Income Taxes Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income before income taxes to the non-GAAP measure of Income Before Income Taxes Excluding Certain Items:
Three months ended April 30,Nine months ended April 30,
2024202320242023
Income before income taxes (GAAP measure)$64,411 $63,033 $179,633 $161,878 
Amortization expense2,365 2,461 7,084 9,350 
Gain on sale of business— (3,770)— (3,770)
Income Before Income Taxes Excluding Certain Items (non-GAAP measure)$66,776 $61,724 $186,717 $167,458 


Income Tax Expense Excluding Certain Items:
Brady is presenting the non-GAAP measure, "Income Tax Expense Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income tax expense to the non-GAAP measure of Income Tax Expense Excluding Certain Items:
Three months ended April 30,Nine months ended April 30,
2024202320242023
Income tax expense (GAAP measure)$13,521 $14,981 $37,874 $36,399 
Amortization expense548 569 1,642 2,203 
Gain on sale of business— (1,431)— (1,431)
Income Tax Expense Excluding Certain Items (non-GAAP measure)$14,069 $14,119 $39,516 $37,171 


Net Income Excluding Certain Items:
Brady is presenting the non-GAAP measure, "Net Income Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income to the non-GAAP measure of Net Income Excluding Certain Items:
Three months ended April 30,Nine months ended April 30,
2024202320242023
Net income (GAAP measure)$50,890 $48,052 $141,759 $125,479 
Amortization expense1,817 1,892 5,442 7,147 
Gain on sale of business— (2,339)— (2,339)
Net Income Excluding Certain Items (non-GAAP measure)$52,707 $47,605 $147,201 $130,287 




Diluted EPS Excluding Certain Items:
Brady is presenting the non-GAAP measure, "Diluted EPS Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income per Class A Nonvoting Common Share to the non-GAAP measure of Diluted EPS Excluding Certain Items (Note that certain amounts will not foot due to rounding):
Three months ended April 30,Nine months ended April 30,
2024202320242023
Net income per Class A Nonvoting Common Share (GAAP measure)$1.05 $0.96 $2.91 $2.51 
Amortization expense0.04 0.04 0.11 0.14 
Gain on sale of business— (0.05)— (0.05)
Diluted EPS Excluding Certain Items (non-GAAP measure)$1.09 $0.95 $3.03 $2.60 


Diluted EPS Excluding Certain Items Guidance:
Fiscal 2024 Expectations
LowHigh
Earnings per Class A Nonvoting Common Share (GAAP measure)$3.93 $4.00 
Amortization expense0.15 0.15 
Diluted EPS Excluding Certain Items (non-GAAP measure)$4.08 $4.15 

\n
\n\nf24q3conferencecallprese\n\n\n
\n
\n
\n\n
F’24 Q3 Financial Results Brady Corporation May 22, 2024
\n

\n

 
\n
\n\n
\n\n
Forward-Looking Statements In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations. The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project,” “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: increased cost of raw materials and labor as well as raw material shortages and supply chain disruptions; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; difficulties in protecting our websites, networks and systems against security breaches; Brady’s ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses; risks associated with the loss of key employees; extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities; litigation, including product liability claims; adverse impacts of regional epidemics or global pandemics; foreign currency fluctuations; potential write-offs of goodwill and other intangible assets; changes in tax legislation and tax rates; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady’s Form 10-K for the year ended July 31, 2023. These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward- looking statements. Brady does not undertake to update its forward-looking statements except as required by law. 2
\n

\n

 
\n
\n\n
\n\n
Q3 F’24 Highlights 3 * Diluted EPS Excluding Certain Items is a non-GAAP measure. See appendix. Organic sales grew 4.5%, with organic growth in both regions.Organic Sales Growth GPM of 51.6% compared to 50.3% in Q3 of F’23. Continued improvement in gross profit margin in F’24.Improved GPM GAAP EPS of $1.05 was up 9.4% over Q3 of last year. Diluted EPS Excluding Certain Items* increased 14.7% to $1.09 in Q3 of F’24 compared to $0.95 in Q3 of F’23. Expanding Earnings per Share Americas & Asia organic sales growth of 4.5%; segment profit increased 1.0%. Europe & Australia organic sales growth of 4.4%; segment profit increased 14.3%. Regional Results Purchased 863k shares for $50.4M. Paid dividends of $11.2M. In a net cash position of $96.7M at April 30, 2024. Returning Capital to our Shareholders
\n

\n

 
\n
\n\n
\n\n
Sales Overview 4 Q3 F’24 SALES: Total sales increased 1.9%. Organic sales increased 4.5%. • Americas & Asia – Organic sales increased 4.5%. • Europe & Australia – Organic sales increased 4.4%. Foreign currency translation decreased sales 0.3%. Divestitures decreased sales 2.3%. $277 $266 $296 $306 $321 $318 $339 $324 $323 $326 $337 $346 $332 $323 $343 $225 $250 $275 $300 $325 $350 Q1 F'21 (4.9%) Q2 F'21 (6.3%) Q3 F'21 6.5% Q4 F'21 12.6% Q1 F'22 7.0% Q2 F'22 13.1% Q3 F'22 9.0% Q4 F'22 9.0% Q1 F'23 6.9% Q2 F'23 6.3% Q3 F'23 1.9% Q4 F'23 6.9% Q1 F'24 2.7% Q2 F'24 1.6% Q3 F'24 4.5% Organic Growth (Decline) SALES (millions of USD) Q3 F’24 SALES COMMENTARY: Organic sales were up 4.9% in the Americas with growth in all major product lines. Asia organic sales were up 1.9% with growth in all countries offsetting a decline in organic sales in China. Organic sales were up 4.7% in Europe with growth in all major product lines. Australia organic sales were up 2.6%.
\n

\n

 
\n
\n\n
\n\n
Gross Profit Margin 5 $135 $130 $149 $148 $155 $149 $164 $163 $155 $156 $170 $176 $172 $162 $17748.9% 48.7% 50.4% 48.2% 48.2% 47.0% 48.4% 50.4% 48.1% 48.0% 50.3% 50.8% 51.7% 50.2% 51.6% 38% 40% 42% 44% 46% 48% 50% 52% $100 $125 $150 $175 $200 Q1 F'21 Q2 F'21 Q3 F'21 Q4 F'21 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 GROSS PROFIT & GPM% (millions of USD) Q3 F’24 – GROSS PROFIT MARGIN: Gross profit margin of 51.6% compared to 50.3% in Q3 of F’23. Organic sales growth from higher gross profit margin products and reduced input costs resulted in increased gross profit margin in Q3 of F’24. Inflation continues, but we are experiencing a reduced rate of inflation in certain geographies.
\n

\n

 
\n
\n\n
\n\n
SG&A Expense 6 Q3 F’24 – SG&A EXPENSE: SG&A expense was 27.9% of sales compared to 27.0% of sales in the same quarter last year. Excluding non-GAAP* items from both periods, SG&A expense was 27.2% of sales compared to 27.4% of sales in the same quarter last year. Inflation continues in certain geographies. We continue to focus on executing sustainable efficiency gains in order to offset cost increases, while making the necessary investments to drive future sales growth. $83 $82 $91 $94 $97 $93 $96 $95 $90 $92 $91 $97 $96 $91 $96 30.0% 30.9% 30.7% 30.6% 30.1% 29.1% 28.4% 29.2% 27.9% 28.3% 27.0% 28.2% 29.0% 28.3% 27.9% 10% 15% 20% 25% 30% 35% $60 $70 $80 $90 $100 $110 $120 Q1 F'21 Q2 F'21 Q3 F'21 Q4 F'21 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 SG&A EXPENSE AND SG&A EXPENSE AS A % OF SALES (millions of USD) * See appendix for non-GAAP measures.
\n

\n

 
\n
\n\n
\n\n
R&D Expense 7 Q3 F’24 – R&D EXPENSE: Several new product launches this quarter, we remain committed to our investments in R&D in order to drive long-term sales growth. We are focused on ensuring that our R&D spend is both efficient and effective. $10.2 $9.9 $11.3 $13.2 $13.9 $14.0 $14.9 $15.8 $13.9 $15.4 $15.7 $16.3 $15.7 $16.8 $17.7 3.7% 3.7% 3.8% 4.3% 4.3% 4.4% 4.4% 4.9% 4.3% 4.7% 4.7% 4.7% 4.7% 5.2% 5.1% 1.5% 2.5% 3.5% 4.5% 5.5% $8.0 $10.0 $12.0 $14.0 $16.0 $18.0 $20.0 Q1 F'21 Q2 F'21 Q3 F'21 Q4 F'21 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 R&D EXPENSE AND R&D EXPENSE AS A % OF SALES (millions of USD)
\n

\n

 
\n
\n\n
\n\n
Income Before Income Taxes 8 $42.2 $39.4 $47.8 $41.6 $44.7 $42.0 $51.3 $54.0 $50.3 $48.5 $63.0 $63.8 $59.4 $55.8 $64.4 $10 $20 $30 $40 $50 $60 $70 Q1 F'21 1.6% Q2 F'21 (7.0%) Q3 F'21 115.7% Q4 F'21 19.4% Q1 F'22 5.8% Q2 F'22 6.7% Q3 F'22 7.3% Q4 F'22 29.7% Q1 F'23 12.6% Q2 F'23 15.4% Q3 F'23 23.0% Q4 F'23 18.2% Q1 F'24 18.0% Q2 F'24 15.1% Q3 F'24 2.2% * Income Before Income Taxes Excluding Certain Items is a non-GAAP measure. See appendix. (millions of USD)INCOME BEFORE INCOME TAXES (GAAP) Q3 F’24 – INCOME BEFORE INCOME TAXES: GAAP Income before income taxes was up 2.2% to $64.4M in Q3 of F’24 compared to $63.0M in Q3 of F’23. Excluding non-GAAP* items from both periods, income before income taxes was up 8.2% to $66.8M in Q3 of F’24 compared to $61.7M in Q3 of F’23. Year-on-Year Growth (Decline)
\n

\n

 
\n
\n\n
\n\n
Net Income & Diluted EPS 9 Q3 F’24 – NET INCOME & DILUTED EPS: GAAP Net Income was $50.9M in Q3 of F’24 compared to $48.1M in Q3 of F’23 (an increase of 5.9%). • Net Income Excluding Certain Items* was $52.7M in Q3 of F’24 compared to $47.6M in Q3 of F’23 (an increase of 10.7%). GAAP Diluted EPS was $1.05 in Q3 of F’24 compared to $0.96 in Q3 of F’23 (an increase of 9.4%). • Diluted EPS Excluding Certain Items* was $1.09 in Q3 of F’24 compared to $0.95 in Q3 of F’23 (an increase of 14.7%). * Net Income Excluding Certain Items and Diluted EPS Excluding Certain Items are non-GAAP measures. See appendix. $33.5 $30.9 $37.3 $28.0 $35.0 $33.8 $40.1 $41.1 $39.4 $38.0 $48.1 $49.4 $47.2 $43.6 $50.9 $20 $30 $40 $50 Q1 F'21 Q2 F'21 Q3 F'21 Q4 F'21 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 NET INCOME (GAAP) (millions of USD) $0.64 $0.59 $0.71 $0.53 $0.67 $0.65 $0.78 $0.81 $0.79 $0.76 $0.96 $1.00 $0.97 $0.90 $1.05 $0.20 $0.40 $0.60 $0.80 $1.00 Q1 F'21 Q2 F'21 Q3 F'21 Q4 F'21 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 DILUTED EPS (GAAP)
\n

\n

 
\n
\n\n
\n\n
Cash Generation 10 CASH FLOW FROM OPERATING ACTIVITIES $62.8 $36.1 $56.0 $50.8 $27.5 ($3.2) $40.9 $53.2 $28.0 $29.4 $72.5 $79.3 $62.3 $36.1 $72.7 -$5 $20 $45 $70 $95 Q1 F'21 188% Q2 F'21 117% Q3 F'21 150% Q4 F'21 181% Q1 F'22 78% Q2 F'22 (9%) Q3 F'22 102% Q4 F'22 130% Q1 F'23 71% Q2 F'23 77% Q3 F'23 151% Q4 F'23 161% Q1 F'24 132% Q2 F'24 83% Q3 F'24 143%% of Net Income CASH FLOWS IN Q3 OF F’24: Overview: Cash flow from operating activities was $72.7M in Q3 of F’24 vs. $72.5M in Q3 of F’23. Year-to-date cash flow from operating activities was up 31.8% from $129.9M to $171.1M. Free cash flow* was $64.4M in Q3 of F’24 compared to $67.7M in Q3 of F’23. Free cash flow decreased primarily due to the construction of a new facility in F’24. Returning Funds to our Shareholders: In Q3 of F’24, we returned a total of $61.6M to our shareholders in the form of dividends and share buybacks. Dividends – Increased our annual dividend for the 38th consecutive year. Share Buybacks – Repurchased 863,365 shares in Q3 of F’24 for $50.4M (average price of $58.41/share). * Free cash flow is calculated as Net Cash Provided by Operating Activities less Capital Expenditures. (millions of USD) (millions of USD) 3 Mos. Ended Apr. 30, 2024 3 Mos. Ended Apr. 30, 2023 9 Mos. Ended Apr. 30, 2024 9 Mos. Ended Apr. 30, 2023 Cash Balance - Beginning of Period 143.9$ 108.2$ 151.5$ 114.1$ Cash Flow from Operating Activities 72.7 72.5 171.1 129.9 Capital Expenditures (8.3) (4.7) (69.2) (12.9) Dividends (11.2) (11.4) (33.9) (34.2) Share Repurchases (50.4) (11.9) (72.2) (29.8) Proceeds from Sale of Business - 8.0 - 8.0 Debt Borrowings / (Repayments) 15.7 (26.4) 14.1 (44.2) Effect of Exchange Rates on Cash (0.6) - (2.8) 2.0 Other (1.3) 0.7 1.9 2.1 Cash Balance - End of Period 160.5$ 135.0$ 160.5$ 135.0$
\n

\n

 
\n
\n\n
\n\n
Net Cash 11 STRONG BALANCE SHEET: April 30, 2024 cash = $160.5M. April 30, 2024 debt = $63.8M. Balance sheet provides flexibility for future organic and inorganic investments. $256 $278 $322 $109 $91 $64 $26 $19 $15 $31 $84 $102 $123 $96 $97 $0 $50 $100 $150 $200 $250 $300 $350 Q1 F'21 Q2 F'21 Q3 F'21 Q4 F'21 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 NET CASH (millions of USD)
\n

\n

 
\n
\n\n
\n\n
F’24 Diluted EPS Guidance GAAP Diluted EPS $3.93 to $4.00 (+12.0% to +14.0% vs. F’23) F’24 Diluted EPS, Excluding Certain Items* $4.08 to $4.15 (+12.1% to +14.0% vs. F’23) Guidance Assumptions: F’24 organic sales growth in the low-single digit percentages. The only difference between GAAP Diluted EPS and Diluted EPS, Excluding Certain Items* F’24 guidance is the impact of amortization expense of $0.15 per share. Full-year income tax rate of approximately 21%. Foreign currency exchange rates as of April 30, 2024. Depreciation and amortization expense of $30M to $32M. Capital expenditures of approximately $75M (inclusive of $55M related to the conversion of previously leased critical manufacturing facilities). 12 * Diluted EPS Excluding Certain Items is a non-GAAP measure. See appendix.
\n

\n

 
\n
\n\n
\n\n
Americas & Asia 13 • Revenues increased 0.9% in Q3 of F’24: • Organic growth = + 4.5%. • Fx decrease = (0.1%). • Divestiture = (3.5%). • Organic sales grew 4.9% in the Americas. Growth in all major product lines and geographies. • Organic sales grew 1.9% in Asia; growth throughout the region more than offset an organic sales decline in China. • Slight increase in segment profit due to organic sales growth in higher gross margin product lines, which was partially offset by additional investment in sales and research & development resources. Q3 F’24 SUMMARY:Q3 F’24 vs. Q3 F’23 (millions of USD) $213 $208 $223 $218 $218 $220 $223 $227 $222 $212 $225 18% 16% 20% 20% 19% 18% 22% 22% 23% 21% 22% 0% 5% 10% 15% 20% 25% $100 $150 $200 $250 $300 Q1 F'22 9.3% 0.9% 8.3% Q2 F'22 13.9% - 8.1% Q3 F'22 9.2% (0.1%) 8.6% Q4 F'22 9.1% (1.0%) 2.8% Q1 F'23 4.0% (1.4%) - Q2 F'23 6.9% (1.0%) - Q3 F'23 1.2% (0.8%) (0.3%) Q4 F'23 5.6% (0.2%) (1.0%) Q1 F'24 3.3% - (1.9%) Q2 F'24 1.2% 0.1% (5.1%) Q3 F'24 4.5% (0.1%) (3.5%) SALES & SEGMENT PROFIT % (millions of USD) Q3 F’24 Q3 F’23 Change Sales $ 224.8 $ 222.8 0.9% Segment Profit 49.7 49.2 + 1.0% Segment Profit % 22.1% 22.1% + 0 bps • Organic sales growth in the low-single digit percentages in F’24. • Continued growth in segment profit. OUTLOOK: Organic For. Curr. Acq. & Div.
\n

\n

 
\n
\n\n
\n\n
Europe & Australia 14 • Revenues increased 3.8% in Q3 of F’24: • Organic growth = + 4.4%. • Fx decrease = (0.6%). • Organic sales grew 4.7% in Europe driven by growth in most major product lines and geographies. • Organic sales grew 2.6% in Australia primarily due to increased sales in the wire identification and product identification product lines. • Segment profit increased primarily due to organic sales growth and improved gross profit margins resulting from product mix and reductions in freight expenses. Q3 F’24 SUMMARY:Q3 F’24 vs. Q3 F’23 (millions of USD) $109 $110 $116 $106 $104 $106 $114 $118 $110 $111 $119 13% 15% 14% 16% 16% 13% 15% 16% 15% 14% 16% 0% 5% 10% 15% $50 $75 $100 $125 $150 Q1 F'22 2.6% 0.6% 8.2% Q2 F'22 11.7% (5.8%) 9.6% Q3 F'22 8.5% (8.2%) 8.7% Q4 F'22 8.8% (13.9%) 1.8% Q1 F'23 12.8% (17.0%) - Q2 F'23 5.2% (8.9%) - Q3 F'23 3.4% (4.8%) - Q4 F'23 9.5% 2.0% - Q1 F'24 1.4% 4.6% - Q2 F'24 2.5% 2.0% - Q3 F'24 4.4% (0.6%) - SALES & SEGMENT PROFIT % Q3 F’24 Q3 F’23 Change Sales $ 118.6 $ 114.3 + 3.8% Segment Profit 19.5 17.1 + 14.3% Segment Profit % 16.5% 15.0% + 150 bps Organic For. Curr. Acquisitions • Organic sales growth in the low-single digit percentages in F’24. • Growth in segment profit. OUTLOOK: (millions of USD)
\n

\n

 
\n
\n\n
\n\n
Investor Relations Brady Contact: Ann Thornton Investor Relations 414-438-6887 Ann_Thornton@bradycorp.com See our website at www.bradycorp.com/investors 15
\n

\n

 
\n
\n\n
\n\n
Appendix GAAP to Non-GAAP Reconciliations
\n

\n

 
\n
\n\n
\n\n
Non-GAAP Reconciliations 17 2024 2023 2024 2023 64,411$ 63,033$ 179,633$ 161,878$ Amortization expense 2,365 2,461 7,084 9,350 Gain on sale of business - (3,770) - (3,770) 66,776$ 61,724$ 186,717$ 167,458$ 2024 2023 2024 2023 13,521$ 14,981$ 37,874$ 36,399$ Amortization expense 548 569 1,642 2,203 Gain on sale of business - (1,431) - (1,431) 14,069$ 14,119$ 39,516$ 37,171$ Income before income taxes Income Before Income Taxes Excluding Certain Items (non-GAAP measure) Income Tax Expense Excluding Certain Items: Brady is presenting the non-GAAP measure, "Income Tax Expense Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income tax expense to the non-GAAP measure of Income Tax Expense Excluding Certain Items: Nine months ended April 30, Income tax expense (GAAP measure) Nine months ended April 30, GAAP to NON-GAAP MEASURES (Unaudited; Dollars in Thousands, Except Per Share Amounts) In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure. Income Before Income Taxes Excluding Certain Items: Brady is presenting the non-GAAP measure, "Income Before Income Taxes Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income before income taxes to the non-GAAP measure of Income Before Income Taxes Excluding Certain Items: Three months ended April 30, Three months ended April 30, Income Tax Expense Excluding Certain Items (non-GAAP measure)
\n

\n

 
\n
\n\n
\n\n
Non-GAAP Reconciliations 18 2024 2023 2024 2023 50,890$ 48,052$ 141,759$ 125,479$ Amortization expense 1,817 1,892 5,442 7,147 Gain on sale of business - (2,339) - (2,339) 52,707$ 47,605$ 147,201$ 130,287$ 2024 2023 2024 2023 $ 1.05 $ 0.96 $ 2.91 $ 2.51 Amortization expense 0.04 0.04 0.11 0.14 Gain on sale of business - (0.05) - (0.05) 1.09$ 0.95$ 3.03$ 2.60$ Diluted EPS Excluding Certain Items Guidance: Low High Earnings per diluted Class A Common Share (GAAP measure) $ 3.93 $ 4.00 Amortization expense 0.15 0.15 Diluted EPS Excluding Certain Items (non-GAAP measure) 4.08$ 4.15$ Three months ended April 30, Diluted EPS Excluding Certain Items: Brady is presenting the non-GAAP measure, "Diluted EPS Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income per Class A Nonvoting Common Share to the non-GAAP measure of Diluted EPS Excluding Certain Items (Note that certain amounts will not foot due to rounding): Nine months ended April 30, Net income per Class A Nonvoting Common Share (GAAP measure) Net Income Excluding Certain Items (non-GAAP measure) Fiscal 2024 Expectations GAAP to NON-GAAP MEASURES (Unaudited; Dollars in Thousands, Except Per Share Amounts) In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure. Diluted EPS Excluding Certain Items (non-GAAP measure) Three months ended April 30, Net Income Excluding Certain Items: Brady is presenting the non-GAAP measure, "Net Income Excluding Certain Items." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income to the non-GAAP measure of Net Income Excluding Certain Items: Nine months ended April 30, Net income (GAAP measure)
\n

\n

 
\n
\n
\n
\n\n\n","error":null}